Renaissance Technologies’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-396,605
| Closed | -$7.54M | – | 3901 |
|
|
2019
Q1 | $7.54M | Buy |
396,605
+344,200
| +657% | +$5.58M | 0.01% | 1543 |
|
|
2018
Q4 | $707K | Buy |
52,405
+20,765
| +66% | +$232K | ﹤0.01% | 2729 |
|
|
2018
Q3 | $351K | Buy |
+31,640
| New | +$317K | ﹤0.01% | 2967 |
|
|
2017
Q1 | – | Sell |
-483,091
| Closed | -$2.37M | – | 3626 |
|
|
2016
Q4 | $2.37M | Buy |
483,091
+280,791
| +139% | +$1.44M | ﹤0.01% | 2136 |
|
|
2016
Q3 | $1M | Sell |
202,300
-32,007
| -14% | -$164K | ﹤0.01% | 2561 |
|
|
2016
Q2 | $1.19M | Buy |
234,307
+108,666
| +86% | +$585K | ﹤0.01% | 2459 |
|
|
2016
Q1 | $717K | Sell |
125,641
-46,066
| -27% | -$322K | ﹤0.01% | 2728 |
|
|
2015
Q4 | $1.78M | Buy |
171,707
+73,307
| +74% | +$995K | ﹤0.01% | 2184 |
|
|
2015
Q3 | $1.82M | Sell |
98,400
-16,620
| -14% | -$321K | ﹤0.01% | 2061 |
|
|
2015
Q2 | $2.24M | Buy |
115,020
+87,920
| +324% | +$1.56M | 0.01% | 1994 |
|
|
2015
Q1 | $476K | Buy |
+27,100
| New | +$455K | ﹤0.01% | 2613 |
|
|
2014
Q4 | – | Sell |
-92,207
| Closed | -$1.16M | – | 3333 |
|
|
2014
Q3 | $1.16M | Buy |
92,207
+53,300
| +137% | +$760K | ﹤0.01% | 1955 |
|
|
2014
Q2 | $608K | Buy |
+38,907
| New | +$572K | ﹤0.01% | 2247 |
|
|
2013
Q3 | – | Sell |
-18,107
| Closed | -$182K | – | 3166 |
|
|
2013
Q2 | $182K | Buy |
+18,107
| New | +$190K | ﹤0.01% | 2539 |
|
Other funds holding OSIR
Renaissance Technologies's OSIR Position: Q2 2019 in Review
Renaissance Technologies sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 396,605 shares — an estimated $7.54M sold.
Renaissance Technologies first reported a position in OSIR in Q2 2013 and held it in 14 quarters. The position peaked at $7.54M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.
- Renaissance Technologies reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
- Renaissance Technologies sold 396,605 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $7.54M.
- Renaissance Technologies first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 14 quarters.
- Renaissance Technologies's Osiris Therapeutics, Inc. Common Stock position peaked at $7.54M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.